Literature DB >> 23542159

Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction.

Bahadir Sarli1, Ahmet O Baktir, Hayrettin Saglam, Huseyin Arinc, Serkan Kurtul, Serdar Sivgin, Mahmut Akpek, Mehmet G Kaya.   

Abstract

OBJECTIVE: In a significant proportion of patients with ST-elevation myocardial infarction (STEMI), microvascular and myocardial reperfusion cannot be regained despite successfully restored thrombolysis in myocardial infarction (TIMI) grade 3 epicardial blood flow. Myocardial blush grade (MBG) is a reliable marker for microvascular patency and predicts short-term and long-term mortality after primary percutaneous coronary intervention (PCI) in patients with acute STEMI, independent of other variables. Mean platelet volume (MPV), a unique measure of platelet size, is an indicator of platelet reactivity. In this study, we aimed to investigate the relation of admission MPV with postinterventional MBG in patients with STEMI and TIMI grade 3 flow at infarct artery after primary PCI.
MATERIALS AND METHODS: Three hundred and ten patients were selected as a study group among patients with STEMI and TIMI grade 3 epicardial blood flow after primary PCI. Blood samples for analysis were obtained during the initial evaluation of patients at the emergency department. MBGs of patients were classified at the end of angioplasty. Patients with MBG 0 and 1 were defined as having poor myocardial blush and patients with MBG 2 and 3 were defined as having normal myocardial blush.
RESULTS: Patients with poor myocardial blush had higher admission MPV (10.5±1.3 to 9.1±1 fl, P<0.001), higher peak creatine kinase myocardial band isoenzyme levels (260±53 to 190±38 U/l, P<0.001), higher white blood cell count (11.3±4 to 10.3±3×10/μl, P=0.012), and lower left ventricular ejection fraction (42±7 to 51±8%, P<0.001) compared with patients with normal myocardial blush. Linear regression analysis showed that admission MPV was significantly associated with postinterventional MBG (coefficient=0.598, P<0.001). Cardiovascular mortality (13-5%, P=0.013) and acute-subacute stent thrombosis at 3 months (12-8%, P=0.028) were significantly higher in patients with poor postinterventional myocardial blush compared with those with normal myocardial blush.
CONCLUSION: The MPV measured at admission is significantly associated with poor postinterventional MBG in patients with STEMI and TIMI grade 3 flow at infarct artery after primary PCI.

Entities:  

Mesh:

Year:  2013        PMID: 23542159     DOI: 10.1097/MCA.0b013e328360eff6

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  5 in total

1.  Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction.

Authors:  B Sarli; M Akpek; A O Baktir; O Sahin; H Saglam; H Arinc; H Odabasi; S Dogan; S Kurtul; Y Dogan; M G Kaya
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

2.  Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking.

Authors:  C E Creutz; S L Snyder; T A Schulz
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

3.  Impact of Mean Platelet Volume on Long-Term Mortality in Chinese Patients with ST-Elevation Myocardial Infarction.

Authors:  Xi-peng Sun; Bo-yu Li; Jing Li; Wei-wei Zhu; Qi Hua
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

Review 4.  Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease.

Authors:  Dong-Hyun Choi; Seong-Ho Kang; Heesang Song
Journal:  Korean J Intern Med       Date:  2016-10-24       Impact factor: 2.884

5.  Vitamin D Level in Patients with Consecutive Acute Coronary Syndrome Is Not Correlated with the Parameters of Platelet Activity.

Authors:  Ewelina A Dziedzic; Jakub S Gąsior; Izabela Sowińska; Marek Dąbrowski; Piotr Jankowski
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.